Bacterial infections are a global health concern, particularly due to the increasing resistance of bacteria to antibiotics. Multi-drug resistance (MDR) is a considerable challenge, and novel approaches are needed to treat bacterial infections. Photodynamic inactivation (PDI) of microorganisms is increasingly recognized as an effective method to inactivate a broad spectrum of bacteria and overcome resistance mechanisms. This study presents the synthesis of a new cationic 5,15-di-imidazolyl porphyrin derivative and the impact of n-octanol/water partition coefficient (logP) values of this class of photosensitizers on PDI efficacy of Escherichia coli. The derivative with logP = –0.5, IP-H-OH2+, achieved a remarkable 3 log CFU reduction of E. coli at 100 nM with only 1.36 J/cm2 light dose at 415 nm, twice as effective as the second-best porphyrin IP-H-Me2+, of logP = –1.35. We relate the rapid uptake of IP-H-OH2+ by E. coli to improved PDI and the very low uptake of a fluorinated derivative, IP-H-CF32+, logP ≈ 1, to its poor performance. Combination of PDI with cinnamaldehyde, a major component of the cinnamon plant known to alter bacteria cell membranes, offered synergic inactivation of E. coli (7 log CFU reduction), using 50 nM of IP-H-OH2+ and just 1.36 J/cm2 light dose. The success of combining PDI with this natural compound broadens the scope of therapies for MDR infections that do not add drug resistance. In vivo studies on a mouse model of wound infection showed the potential of cationic 5,15-di-imidazolyl porphyrins to treat clinically relevant infected wounds. Graphical Abstract
1 October 2021 in Journal of Organometallic Chemistry
In this work, multicomponent trimethoprim-based pharmaceutical solid systems were developed by mechanochemistry, using coformers from the GRAS list and other active pharmaceutical ingredients. The choice of coformers took into account their potential to increase the aqueous solubility/dissolution rate of TMP or its antibacterial activity. All the binary systems were characterized by thermal analysis, powder X-ray diffraction and infrared spectroscopy, and 3 equimolar systems with FTIR pointing to salts, and 4 eutectic mixtures were identified. The intrinsic dissolution rate of TMP in combination with nicotinic acid (a salt) and with paracetamol (eutectic mixture) were 25% and 5% higher than for pure TMP, respectively. For both Gram-positive and -negative strains, the antibacterial activity of TMP with some of the coformers was improved, since the dosage used was lower than the TMP control. A significant increase in antibacterial activity against E. coli was found for the eutectic mixture with curcumin, with the best results being obtained for the eutectic and equimolar mixtures with ciprofloxacin. Combining trimethoprim with coformers offers an interesting alternative to using trimethoprim alone: multicomponent forms with enhanced TMP dissolution rates were identified, as well as combinations showing enhanced antibacterial activity relatively to the pure drug.
Although complexes of the paramagnetic Gd(III) ion have been used with great success for the past 40 years to enhance image contrast in magnetic resonance imaging (MRI), important challenges such as improving the relaxation efficacy, the specificity, the safety, and the environmental impact of these agents remain in this field. Thanks to a collaborative effort between the Centre of Molecular Biophysics in Orléans, France and the Coimbra Chemistry Centre - Institute of Molecular Sciences in Coimbra, Portugal, there have been important advances in the chemistry of MRI probes. The authors have developed rigid, medium-sized, and bishydrated Gd(III) complexes specifically optimized for high-field applications with successful validation in vivo. For the specific targeting of amyloid peptides implicated in many pathologies such as Alzheimer’s disease and diabetes, they have designed benzothiazole-derivative metal chelates with detection potential in MRI, optical, and nuclear imaging modalities. The authors have gained valuable insights into the aggregation behavior of these complexes in solution and how this affects peptide binding affinity. More recently, manganese porphyrin complexes have been investigated with the objective of visualizing the tissue redox state based on the Mn(II)/Mn(III) redox switch, which can be followed not only in classical 1 H detection but also in 19 F MRI.
Tetrapyrrolic macrocycles, particularly meso-imidazolyl porphyrins and their chlorin derivatives, have gained significant attention as potent photosensitizers for antimicrobial photodynamic inactivation (aPDI). This chapter explores the synthetic methodologies to obtain two families comprising di-cationic and tetra-cationic imidazolyl porphyrins and chlorin derivatives. Their structure-activity relationships on aPDI, and broad-spectrum efficacy against Gram-positive and Gram-negative bacteria, biofilms, and viruses, including SARS-CoV-2 are discussed. The design of cationic imidazolyl porphyrins enhances bacterial uptake through electrostatic interactions, overcoming the structural barriers of bacterial membranes and biofilms. Studies highlight the superior efficacy of zinc-complexed tetra-cationic imidazolyl porphyrins in planktonic bacteria, while smaller, di-cationic derivatives demonstrate enhanced biofilm penetration and inactivation. In vivo studies confirm the effectiveness of chlorin-based photosensitizers in wound infection models, demonstrating significant bacterial load reduction with minimal cytotoxicity to host tissues. Additionally, the combination of aPDI with antibiotics, such as ciprofloxacin, and natural antimicrobial agents, such as cinnamaldehyde, significantly enhances therapeutic efficacy. The antiviral potential of these photosensitizers is also explored, with dicationic imidazolyl chlorins achieving near-total SARS-CoV-2 inactivation at low concentrations and light doses. These findings underscore the promising role of cationic imidazolyl porphyrins in developing innovative, light-activated antimicrobial and antiviral strategies, addressing the urgent need for effective treatments against multidrug-resistant pathogens.